Showing results (71-80 of 105) with videos related to
Sort By:
Pageof 11
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 2, 2005
Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRIGeorge C Newman, Frank E Hospod, Clifford S Patlak, et al.Annals of Neurology|August 5, 2004
Folic acid supplementation enhances repair of the adult central nervous systemBermans J Iskandar, Aaron Nelson, Daniel Resnick, et al.European Journal of Heart Failure|July 17, 2019
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristicsJohn J V McMurray, David L DeMets, Silvio E Inzucchi, et al.Journal of Cardiac Failure|February 11, 2005
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot studyMilton Packer, John McMurray, Barry M Massie, et al.Circulation|October 23, 2002
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) studyMilton Packer, Michael B Fowler, Ellen B Roecker, et al.Prevention Science : the Official Journal of the Society for Prevention Research|April 8, 2015
Standards of Evidence for Efficacy, Effectiveness, and Scale-up Research in Prevention Science: Next GenerationDenise C Gottfredson, Thomas D Cook, Frances E M Gardner, et al.Journal for Vascular Ultrasound : JVU|August 11, 2025
Clinical Risk Factors for Stroke and Associations with Microembolic Signals on Transcranial DopplerAbdullah A Adil, Carol C Mitchell, Thomas D Cook, et al.Diabetes Care|October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering TherapyKieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.American Heart Journal|May 28, 2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study designAmish N Raval, Thomas D Cook, Henricus J Duckers, et al.JAMA|September 18, 2003
Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trialChristopher M O'Connor, Michael W Dunne, Marc A Pfeffer, et al.Pageof 11